These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29622456)

  • 1. β-Blocker treatment and prognosis in acute coronary syndrome associated with cocaine consumption: The RUTI-Cocaine Study.
    Cediel G; Carrillo X; García-García C; Rueda F; Oliveras T; Labata C; Serra J; Ferrer M; de Diego O; Bayés-Genís A
    Int J Cardiol; 2018 Jun; 260():7-10. PubMed ID: 29622456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in prevalence and outcomes of acute coronary syndrome associated with cocaine consumption: The RUTI-cocaine study.
    Carrillo X; Vilalta V; Cediel G; Fernandez-Nofrerias E; Rodriguez-Leor O; Mauri J; Abdul Jawad-Altisent O; Garcia-Garcia C; Serra J; Bayes-Genis A
    Int J Cardiol; 2019 May; 283():23-27. PubMed ID: 30595359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute coronary syndrome and cocaine use: 8-year prevalence and inhospital outcomes.
    Carrillo X; Curós A; Muga R; Serra J; Sanvisens A; Bayes-Genis A
    Eur Heart J; 2011 May; 32(10):1244-50. PubMed ID: 21266375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-blocker dosage and outcomes after acute coronary syndrome.
    Allen JE; Knight S; McCubrey RO; Bair T; Muhlestein JB; Goldberger JJ; Anderson JL
    Am Heart J; 2017 Feb; 184():26-36. PubMed ID: 27892884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study.
    Iannaccone M; D Ascenzo F; De Filippo O; Gagliardi M; Southern DA; Raposeiras-Roubín S; Abu-Assi E; Henriques JPS; Saucedo J; González-Juanatey JR; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Huczek Z; Nie SP; Fujii T; Correia L; Kawashiri MA; García-Acuña JM; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Kowara M; Filipiak K; Wang X; Yan Y; Fan JY; Ikari Y; Nakahashi T; Sakata K; Yamagishi M; Moretti C; Gaita F; Kalpak O; Kedev S
    Am J Cardiovasc Drugs; 2017 Feb; 17(1):61-71. PubMed ID: 27738920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
    Lanfear DE; Jones PG; Marsh S; Cresci S; McLeod HL; Spertus JA
    JAMA; 2005 Sep; 294(12):1526-33. PubMed ID: 16189366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome (from the National Cardiovascular Data Registry).
    Gupta N; Washam JB; Mountantonakis SE; Li S; Roe MT; de Lemos JA; Arora R
    Am J Cardiol; 2014 Mar; 113(5):749-56. PubMed ID: 24388623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underuse of beta-blockers by patients with COPD and co-morbid acute coronary syndrome: A nationwide follow-up study in New Zealand.
    Parkin L; Quon J; Sharples K; Barson D; Dummer J
    Respirology; 2020 Feb; 25(2):173-182. PubMed ID: 31401813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel oral anticoagulants in acute coronary syndrome.
    Costopoulos C; Niespialowska-Steuden M; Kukreja N; Gorog DA
    Int J Cardiol; 2013 Sep; 167(6):2449-55. PubMed ID: 22989603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of Β-blocker therapy in cocaine-associated heart failure.
    Lopez PD; Akinlonu A; Mene-Afejuku TO; Dumancas C; Saeed M; Cativo EH; Visco F; Mushiyev S; Pekler G
    Int J Cardiol; 2019 Feb; 277():153-158. PubMed ID: 30146248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes.
    Nanchen D; Gencer B; Muller O; Auer R; Aghlmandi S; Heg D; Klingenberg R; Räber L; Carballo D; Carballo S; Matter CM; Lüscher TF; Windecker S; Mach F; Rodondi N
    Circulation; 2016 Sep; 134(10):698-709. PubMed ID: 27462068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of hospitalization period and five-year follow-up of patients admitted with acute coronary syndrome following coronary artery bypass graft surgery].
    Can LH; Kayıkçıoğlu M; Yavuzgil O; Kültürsay H; Soydan I
    Turk Kardiyol Dern Ars; 2010 Sep; 38(6):387-92. PubMed ID: 21200116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute coronary syndrome in young adults: the Thai ACS Registry.
    Tungsubutra W; Tresukosol D; Buddhari W; Boonsom W; Sanguanwang S; Srichaiveth B;
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():81-90. PubMed ID: 18431890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the role of beta-blockers in a contemporary treatment cohort of patients with acute coronary syndrome? A propensity-score matching analysis.
    Timóteo AT; Rosa SA; Cruz M; Moreira RI; Carvalho R; Ferreira ML; Ferreira RC
    Rev Port Cardiol (Engl Ed); 2018 Nov; 37(11):901-908. PubMed ID: 30454912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.
    Looi KL; Chow KL; Looi JL; Lee M; Halliday S; White H; Ellis C
    N Z Med J; 2011 Sep; 124(1343):18-27. PubMed ID: 21964009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of in-hospital outcomes for beta-blocker use versus non-beta blocker use in patients presenting with cocaine-associated chest pain.
    Fanari Z; Kennedy KK; Lim MJ; Laddu AA; Stolker JM
    Am J Cardiol; 2014 Jun; 113(11):1802-6. PubMed ID: 24742472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Li C; Sun Y; Shen X; Yu T; Li Q; Ruan G; Zhang L; Huang Q; Zhuang H; Huang J; Ni L; Wang L; Jiang J; Wang Y; Wang DW
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of beta-blocker therapy at discharge with clinical outcomes in patients without heart failure or left ventricular systolic dysfunction after acute coronary syndrome: An updated systematic review and meta-analysis.
    Hu MJ; Wang XN; Tan JS; Yang YJ
    Arch Cardiovasc Dis; 2022 Dec; 115(12):637-646. PubMed ID: 36376209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.